284 related articles for article (PubMed ID: 6204542)
1. Bioactivity of cholecystokinin analogues: CCK-8 is not more potent than CCK-33.
Solomon TE; Yamada T; Elashoff J; Wood J; Beglinger C
Am J Physiol; 1984 Jul; 247(1 Pt 1):G105-11. PubMed ID: 6204542
[TBL] [Abstract][Full Text] [Related]
2. Biological activity of the C-terminal octapeptide of cholecystokinin, of three of its analogues and of caerulein in the dog.
Meyer FD; Gyr K; Kayasseh L; Jeker L; Wall M; Trzeciak A; Gillessen D
Experientia; 1980 Apr; 36(4):434-6. PubMed ID: 7379916
[TBL] [Abstract][Full Text] [Related]
3. Ceruletide, ceruletide analogues and cholecystokinin octapeptide (CCK-8): effects on isolated intestinal preparations and gallbladders of guinea pigs and mice.
Zetler G
Peptides; 1984; 5(4):729-36. PubMed ID: 6093075
[TBL] [Abstract][Full Text] [Related]
4. Properties of receptors for gastrin and CCK on gastric smooth muscle cells.
Menozzi D; Gardner JD; Jensen RT; Maton PN
Am J Physiol; 1989 Jul; 257(1 Pt 1):G73-9. PubMed ID: 2473654
[TBL] [Abstract][Full Text] [Related]
5. N alpha-carboxyacyl analogues of CCK with a substituted Gly: interaction with pancreatic and gallbladder CCK receptors.
von Schrenck T; Müller K; Schulze C; Mirau S; Raedler A; Greten H
Peptides; 1993; 14(6):1309-15. PubMed ID: 7510882
[TBL] [Abstract][Full Text] [Related]
6. Glucose-dependent insulinotropic action of cholecystokinin and caerulein in the isolated perfused rat pancreas.
Sakamoto C; Otsuki M; Ohki A; Yuu H; Maeda M; Yamasaki T; Baba S
Endocrinology; 1982 Feb; 110(2):398-402. PubMed ID: 6173205
[TBL] [Abstract][Full Text] [Related]
7. Discrepancies between the doses of cholecystokinin or caerulein-stimulating exocrine and endocrine responses in perfused isolated rat pancreas.
Otsuki M; Sakamoto C; Yuu H; Maeda M; Morita S; Ohki A; Kobayashi N; Terashi K; Okano K; Baba S
J Clin Invest; 1979 Mar; 63(3):478-84. PubMed ID: 372241
[TBL] [Abstract][Full Text] [Related]
8. Exocrine pancreatic secretion in response to a new CCK-analog, CCK33 and caerulein in dogs.
Beglinger C; Solomon TE; Gyr K; Moroder L; Wünsch E
Regul Pept; 1984 Jul; 8(4):291-6. PubMed ID: 6548569
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of CCK receptor antagonists on rat pancreatic secretion in vivo.
Niederau M; Niederau C; Strohmeyer G; Grendell JH
Am J Physiol; 1989 Jan; 256(1 Pt 1):G150-7. PubMed ID: 2463767
[TBL] [Abstract][Full Text] [Related]
10. Cyclic cholecystokinin analogues that are highly selective for rat and guinea pig central cholecystokinin receptors.
Rodriguez M; Lignon MF; Galas MC; Amblard M; Martinez J
Mol Pharmacol; 1990 Sep; 38(3):333-41. PubMed ID: 1698251
[TBL] [Abstract][Full Text] [Related]
11. Cholecystokinin (pancreozymin). Synthesis and properties of the N alpha-acetyl-derivative of cholecystokinin 27-33.
Bodanszky M; Tolle JC; Gardner JD; Walker MD; Mutt V
Int J Pept Protein Res; 1980 Nov; 16(5):402-11. PubMed ID: 6163740
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists.
Makovec F; Bani M; Cereda R; Chisté R; Pacini MA; Revel L; Rovati LA; Rovati LC; Setnikar I
Arzneimittelforschung; 1987 Nov; 37(11):1265-8. PubMed ID: 3440035
[TBL] [Abstract][Full Text] [Related]
13. Effects of cholecystokinin (CCK)-JMV-180 on the CCK receptors of rabbit pancreatic acini and gallbladder smooth muscle.
Taniguchi H; Nagasaki M; Tamaki H
Jpn J Pharmacol; 1995 Mar; 67(3):219-24. PubMed ID: 7543168
[TBL] [Abstract][Full Text] [Related]
14. The action of scretin, cholecystokinin-pancreozymin and caerulein on pancreatic secretion in the rat.
Dockray GJ
J Physiol; 1972 Sep; 225(3):679-92. PubMed ID: 5076393
[TBL] [Abstract][Full Text] [Related]
15. Contractile responses of canine gastric muscle to peptides of the cholecystokinin group.
Milenov K; Golenhofen K
J Auton Pharmacol; 1987 Jun; 7(2):145-56. PubMed ID: 3654682
[TBL] [Abstract][Full Text] [Related]
16. Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat.
Scarpignato C; Varga G; Dobronyi I; Papp M
Br J Pharmacol; 1989 Mar; 96(3):661-9. PubMed ID: 2470456
[TBL] [Abstract][Full Text] [Related]
17. Pig pancreatic acinar cells possess predominantly the CCK-B receptor subtype.
Morisset J; Levenez F; Corring T; Benrezzak O; Pelletier G; Calvo E
Am J Physiol; 1996 Aug; 271(2 Pt 1):E397-402. PubMed ID: 8770035
[TBL] [Abstract][Full Text] [Related]
18. Biological activity of canine intestinal cholecystokinin-58.
Eysselein VE; Deveney CW; Sankaran H; Reeve JR; Walsh JH
Am J Physiol; 1983 Aug; 245(2):G313-20. PubMed ID: 6192728
[TBL] [Abstract][Full Text] [Related]
19. Comparison between the synthetic cholecystokinin analogues caerulein and Thr28NlE31CCK25-33(CCK9) with regards to plasma bioactivity, degradation rate and stimulation of pancreatic exocrine function.
Mössner J; Sprenger C; Secknus R; Kestel W; Fischbach W
Z Gastroenterol; 1991 Feb; 29(2):59-64. PubMed ID: 1714671
[TBL] [Abstract][Full Text] [Related]
20. Action of cholecystokinin analogues on exocrine and endocrine rat pancreas.
Otsuki M; Okabayashi Y; Ohki A; Oka T; Fujii M; Nakamura T; Sugiura N; Yanaihara N; Baba S
Am J Physiol; 1986 Apr; 250(4 Pt 1):G405-11. PubMed ID: 2421584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
